CD33 is highly expressed in acute promyelocytic leukemia (APL), NPM1-mutated AML, and FLT3/ITD mutated AML, whereas expression is usually low in leukemias with core-binding factor translocations (45). The gene discussed is CD33; the disease is acute myeloid leukemia.